Your browser doesn't support javascript.
loading
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.
Lim, Lisha Qiu Jin; Adler, Lital; Hajaj, Emma; Soria, Leandro R; Perry, Rotem Ben-Tov; Darzi, Naama; Brody, Ruchama; Furth, Noa; Lichtenstein, Michal; Bab-Dinitz, Elizabeta; Porat, Ziv; Melman, Tevie; Brandis, Alexander; Malitsky, Sergey; Itkin, Maxim; Aylon, Yael; Ben-Dor, Shifra; Orr, Irit; Pri-Or, Amir; Seger, Rony; Shaul, Yoav; Ruppin, Eytan; Oren, Moshe; Perez, Minervo; Meier, Jordan; Brunetti-Pierri, Nicola; Shema, Efrat; Ulitsky, Igor; Erez, Ayelet.
Afiliación
  • Lim LQJ; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Adler L; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Hajaj E; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Soria LR; Department of Medicine D, Beilinson Hospital, Petah Tikva, Israel.
  • Perry RB; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
  • Darzi N; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Brody R; Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.
  • Furth N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Lichtenstein M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Bab-Dinitz E; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Porat Z; Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Melman T; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Brandis A; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Malitsky S; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Itkin M; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Aylon Y; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Ben-Dor S; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Orr I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Pri-Or A; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Seger R; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Shaul Y; The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
  • Ruppin E; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Oren M; Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Perez M; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Meier J; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Brunetti-Pierri N; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Shema E; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
  • Ulitsky I; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
  • Erez A; Department of Translational Medicine, Medical Genetics, University of Naples Federico II, Naples, Italy.
Nat Metab ; 6(7): 1417, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38965441

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Metab Año: 2024 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Metab Año: 2024 Tipo del documento: Article País de afiliación: Israel